Literature DB >> 21113667

Association between N142D genetic polymorphism of GSTO2 and susceptibility to colorectal cancer.

Mohammad Masoudi1, Iraj Saadat, Shahpour Omidvari, Mostafa Saadat.   

Abstract

Expression pattern analysis has been revealed that glutathione S-transferase omega 2 (GSTO2, a member of class omega) is ubiquitously expressed. Over expression of GSTO2 induced apoptosis. The gene encoding GSTO2 was localized to human chromosome 10q24.3, a region that may harbor gene(s) involved in the developing of colorectal cancer. To investigate the association between GSTO2 N142D genetic polymorphism and susceptibility to colorectal cancer the present study was done. We studied 63 (26 females, 37 males) colorectal cancer patients and 126 (52 females, 74 males) healthy individuals. The control subjects were frequency matched for age and gender with the colorectal cancer group. The genotypes were performed using RFLP-PCR method. The ND and DD genotypes were not associated with risk of colorectal cancer, in comparison with the NN genotype. Family history for cancer in the first degree of relatives significantly differed between cases and controls (P = 0.012). The profiles of GSTO2 genotypes and family history in control and cancerous groups were compared to each other. Subjects with NN genotype and positive family history significantly were at high risk to develop colorectal cancer in comparison with subjects with DD or ND genotypes and negative family history (P = 0.003). Present findings indicating that GSTO2 NN genotype increase the risk of colorectal cancer in persons with positive family history for cancer in the first degree relatives.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21113667     DOI: 10.1007/s11033-010-0555-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

1.  Characterization of the human Omega class glutathione transferase genes and associated polymorphisms.

Authors:  Astrid K Whitbread; Natasha Tetlow; Helen J Eyre; Grant R Sutherland; Philip G Board
Journal:  Pharmacogenetics       Date:  2003-03

2.  Glutathione S-transferase omega 1 and omega 2 pharmacogenomics.

Authors:  Baidehi Mukherjee; Oreste E Salavaggione; Linda L Pelleymounter; Irene Moon; Bruce W Eckloff; Daniel J Schaid; Eric D Wieben; Richard M Weinshilboum
Journal:  Drug Metab Dispos       Date:  2006-04-25       Impact factor: 3.922

Review 3.  An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.

Authors:  Zengnan Mo; Yong Gao; Yunfei Cao; Feng Gao; Lijuan Jian
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

4.  Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer.

Authors:  Julide Altinisik; Zinnet B Balta; Gunay Aydin; Turgut Ulutin; Nur Buyru
Journal:  Mol Biol Rep       Date:  2009-08-08       Impact factor: 2.316

5.  Identification, characterization, and crystal structure of the Omega class glutathione transferases.

Authors:  P G Board; M Coggan; G Chelvanayagam; S Easteal; L S Jermiin; G K Schulte; D E Danley; L R Hoth; M C Griffor; A V Kamath; M H Rosner; B A Chrunyk; D E Perregaux; C A Gabel; K F Geoghegan; J Pandit
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

6.  Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily.

Authors:  R A Zakharyan; A Sampayo-Reyes; S M Healy; G Tsaprailis; P G Board; D C Liebler; H V Aposhian
Journal:  Chem Res Toxicol       Date:  2001-08       Impact factor: 3.739

Review 7.  XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.

Authors:  Zhibin Hu; Hongxia Ma; Feng Chen; Qingyi Wei; Hongbing Shen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

8.  Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran).

Authors:  Parisa Mohamadynejad; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2007-09-14       Impact factor: 2.316

9.  Influence of the glutathione s-transferase gene polymorphisms on the susceptibility to basal cell skin carcinoma.

Authors:  Janaína L Leite; Elaine C Morari; Fabiana Granja; Gabriela M Campos; Ana C T Guilhen; Laura S Ward
Journal:  Rev Med Chil       Date:  2007-04-26       Impact factor: 0.553

10.  Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases.

Authors:  M Karoui; C Tresallet; C Julie; U Zimmermann; F Staroz; A Brams; C Muti; C Boulard; A-M Robreau; H Puy; R Malafosse; C Penna; F-R Pruvot; J P Thiery; C Boileau; P Rougier; B Nordlinger; F Radvanyi; B Franc; H Hofmann-Radvanyi
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

View more
  10 in total

1.  Glutathione S-transferase O2 gene rs157077 polymorphism predicts response to transarterial chemoembolization in hepatocellular carcinoma.

Authors:  Zhixin Wang; Kai Qu; Zhichao Huang; Xinsen Xu; Jingyao Zhang; Li Zhang; Sinan Liu; Hulin Chang; Ting Lin; Yamin Liu; Wenquan Niu; Chang Liu
Journal:  Tumour Biol       Date:  2015-04-03

2.  A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population.

Authors:  Jie Chen; Liang Ma; Ning-Fu Peng; Shi-Jun Wang; Le-Qun Li
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

3.  Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients.

Authors:  Kai Qu; Su-Shun Liu; Zhi-Xin Wang; Zi-Chao Huang; Si-Nan Liu; Hu-Lin Chang; Xin-Sen Xu; Ting Lin; Ya-Feng Dong; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.

Authors:  Tatjana Djukic; Tatjana Simic; Tanja Radic; Marija Matic; Marija Pljesa-Ercegovac; Sonja Suvakov; Vesna Coric; Tatjana Pekmezovic; Ivana Novakovic; Dejan Dragicevic; Ana Savic-Radojevic
Journal:  Int Urol Nephrol       Date:  2015-02-26       Impact factor: 2.370

5.  Influence of GSTO2 (N142D) genetic polymorphism on acute renal rejection.

Authors:  Nioosha Nekooie-Marnany; Iraj Saadat; Mohammad-Hossein Karimi; Jamshid Roozbeh; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2013-05-07       Impact factor: 2.316

6.  Association of glutathione S-transferase omega gene polymorphisms with progression of head and neck cancer.

Authors:  S Sanguansin; S Petmitr; P O-Charoenrat; W Pongstaporn
Journal:  Mol Biol Rep       Date:  2012-10-20       Impact factor: 2.316

7.  Genetic polymorphisms in Glutathione S-transferase Omega (GSTO) and cancer risk: a meta-analysis of 20 studies.

Authors:  You-Tao Xu; Jun Wang; Rong Yin; Man-Tang Qiu; Lei Xu; Jie Wang; Lin Xu
Journal:  Sci Rep       Date:  2014-10-10       Impact factor: 4.379

8.  Association of GSTO2 (N142D) Genetic Polymorphism and Acute Rejection of Liver.

Authors:  M Khosravi; I Saadat; M H Karimi; S A Malek Hosseini
Journal:  Int J Organ Transplant Med       Date:  2016-08-01

9.  Glutathione S-transferase Omega 2 Genetic Polymorphism and Risk of Hepatic Failure that Lead to Liver Transplantation in Iranian Population.

Authors:  M Khosravi; I Saadat; M H Karimi; B Geramizadeh; M Saadat
Journal:  Int J Organ Transplant Med       Date:  2013

10.  Proteomics analysis of colon cancer progression.

Authors:  Saira Saleem; Sahrish Tariq; Iffat Aleem; Muhammad Tahseen; Aribah Atiq; Sadia Hassan; Muhammad Abu Bakar; Shahid Khattak; Aamir Ali Syed; Asad Hayat Ahmad; Mudassar Hussain; Muhammed Aasim Yusuf; Chris Sutton
Journal:  Clin Proteomics       Date:  2019-12-28       Impact factor: 3.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.